Christoph Correll to Child
This is a "connection" page, showing publications Christoph Correll has written about Child.
Connection Strength
0.146
-
Editorial Perspective: Challenges of research focusing on child and adolescent mental health during the COVID-19 era: what studies are needed? J Child Psychol Psychiatry. 2022 01; 63(1):122-125.
Score: 0.029
-
Mullerian inhibiting substance, sex hormone binding globulin and sex hormone levels in stimulant-naïve, first-diagnosed prepubertal boys with attention-deficit/hyperactivity disorder: comparison with matched healthy controls as well as before and after oros-methylpenidate treatment. Int J Psychiatry Clin Pract. 2019 Nov; 23(4):251-257.
Score: 0.025
-
Technology-Assisted Parent Training Programs for Children and Adolescents With Disruptive Behaviors: A Systematic Review. J Clin Psychiatry. 2017 Sep/Oct; 78(8):e957-e969.
Score: 0.022
-
Extent, Time Course, and Moderators of Antipsychotic Treatment in Youth With Mood Disorders: Results of a Meta-Analysis and Meta-Regression Analyses. J Clin Psychiatry. 2017 Mar; 78(3):347-357.
Score: 0.021
-
Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial. J Am Acad Child Adolesc Psychiatry. 2019 11; 58(11):1062-1078.
Score: 0.006
-
Mobility for All? J Am Acad Child Adolesc Psychiatry. 2018 10; 57(10):792-793.
Score: 0.006
-
National Patterns of Commonly Prescribed Psychotropic Medications to Young People. J Child Adolesc Psychopharmacol. 2018 04; 28(3):158-165.
Score: 0.006
-
Validation study of the early onset schizophrenia diagnosis in the Danish Psychiatric Central Research Register. Eur Child Adolesc Psychiatry. 2018 Aug; 27(8):965-975.
Score: 0.006
-
Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial. Psychopharmacology (Berl). 2018 03; 235(3):681-693.
Score: 0.006
-
Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers. J Clin Psychiatry. 2017 Jul; 78(7):e744-e781.
Score: 0.005
-
Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial. Lancet Psychiatry. 2017 08; 4(8):605-618.
Score: 0.005
-
Early detection and integrated care for adolescents and young adults with severe psychotic disorders: rationales and design of the Integrated Care in Early Psychosis Study (ACCESS III). Early Interv Psychiatry. 2018 02; 12(1):96-106.
Score: 0.005
-
Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychotics. J Child Adolesc Psychopharmacol. 2015 May; 25(4):351-61.
Score: 0.005